Sector Expert: Patrick Dolezal

LifeSci Capital



Recent Quotes

"DRRX is a biopharmaceutical company with a rich development pipeline that includes an epigenetic regulator program and a portfolio of 505(b)(2) programs."

— Patrick Dolezal, LifeSci Capital (6/29/17)
more >



Due to permission requirements, not all quotes are shown.